From ASCO-immunotherapy: programming cancer cell death.

Nature reviews. Clinical oncology ·Vol. 9 ·No. 8 ·2012-06-19 ·Pages 427

Kirk R

Abstract

暂无摘要

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Kirk Rebecca

References (2)

2 references, click to expand

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
N Engl J Med. 2012 Jun 28;366(26):2443-54 PMID: 22658127
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
N Engl J Med. 2012 Jun 28;366(26):2455-65 PMID: 22658128

Article Info

Journal

Nature reviews. Clinical oncology

Abbr.

Nat Rev Clin Oncol

ISSN

1759-4782

DOI

Published

2012-06-19

Epub

2012-00-19

Pages

427

Language

English

Region

England

NLM ID

101500077

Corrections

CommentOn

PMID: 22658127

CommentOn

PMID: 22658128

External Links

Analysis Services